Variant report

Variant	nsv520128
Chromosome Location	chr5:16737513-16746784
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:277)
CpG islands
(count:550)
Chromatin interactive
region (count:14)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:277 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:16744451-16745115	HepG2	liver:	n/a	n/a
2	ATF2	chr5:16741921-16742549	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr5:16741571-16742550	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr5:16740175-16741547	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL11A	chr5:16741039-16741292	H1-hESC	embryonic stem cell:	n/a	n/a
6	BRCA1	chr5:16740663-16741478	H1-hESC	embryonic stem cell:	n/a	chr5:16741308-16741315
7	CEBPB	chr5:16744808-16745070	H1-hESC	embryonic stem cell:	n/a	chr5:16744936-16744949 chr5:16744938-16744949 chr5:16744936-16744947
8	CEBPB	chr5:16737256-16737607	H1-hESC	embryonic stem cell:	n/a	chr5:16737338-16737355
9	CEBPB	chr5:16737317-16737661	HepG2	liver:	n/a	chr5:16737338-16737355
10	CEBPB	chr5:16744770-16745076	IMR90	lung:	n/a	chr5:16744936-16744949 chr5:16744938-16744949 chr5:16744936-16744947
11	CEBPB	chr5:16740588-16741505	H1-hESC	embryonic stem cell:	n/a	chr5:16741343-16741354 chr5:16741343-16741354 chr5:16741341-16741354 chr5:16741338-16741355 chr5:16741341-16741352
12	CEBPB	chr5:16741157-16741498	IMR90	lung:	n/a	chr5:16741343-16741354 chr5:16741343-16741354 chr5:16741341-16741354 chr5:16741338-16741355 chr5:16741341-16741352
13	CEBPB	chr5:16743613-16744076	HepG2	liver:	n/a	chr5:16743974-16743985
14	CEBPB	chr5:16741234-16741430	HepG2	liver:	n/a	chr5:16741343-16741354 chr5:16741343-16741354 chr5:16741341-16741354 chr5:16741338-16741355 chr5:16741341-16741352
15	CEBPB	chr5:16746448-16746652	HepG2	liver:	n/a	chr5:16746621-16746632
16	CEBPB	chr5:16744745-16745118	HepG2	liver:	n/a	chr5:16744936-16744949 chr5:16744938-16744949 chr5:16744936-16744947
17	CEBPB	chr5:16744812-16744997	HepG2	liver:	n/a	chr5:16744936-16744949 chr5:16744938-16744949 chr5:16744936-16744947
18	CEBPB	chr5:16744829-16745084	K562	blood:	n/a	chr5:16744936-16744949 chr5:16744938-16744949 chr5:16744936-16744947
19	CHD1	chr5:16736107-16738493	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD1	chr5:16740537-16742462	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD2	chr5:16740630-16741502	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr5:16741142-16741273	GM12878	blood:	n/a	n/a
23	CTCF	chr5:16741140-16741290	A549	lung:	n/a	n/a
24	CTCF	chr5:16741340-16741490	HEEpiC	esophagus:	n/a	n/a
25	CTCF	chr5:16741198-16741237	LNCaP	prostate:	n/a	n/a
26	CTCF	chr5:16741100-16741250	WERI-Rb-1	eye:	n/a	n/a
27	CTCF	chr5:16741160-16741310	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr5:16741160-16741310	AoAF	blood vessel:	n/a	n/a
29	CTCF	chr5:16741180-16741330	BJ	skin:	n/a	n/a
30	CTCF	chr5:16741140-16741290	HMF	breast:	n/a	n/a
31	CTCF	chr5:16741060-16741210	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr5:16741080-16741230	AoAF	blood vessel:	n/a	n/a
33	CTCF	chr5:16741160-16741310	HPF	lung:	n/a	n/a
34	CTCF	chr5:16741161-16741245	Medullo	brain:	n/a	n/a
35	CTCF	chr5:16741200-16741350	HEEpiC	esophagus:	n/a	n/a
36	CTCF	chr5:16741180-16741330	HMEC	breast:	n/a	n/a
37	CTCF	chr5:16741160-16741310	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr5:16741020-16741170	AG09319	gingival:	n/a	n/a
39	CTCF	chr5:16741194-16741211	LNCaP	prostate:	n/a	n/a
40	CTCF	chr5:16741040-16741190	HVMF	connective:	n/a	n/a
41	CTCF	chr5:16741100-16741250	Caco-2	colon:	n/a	n/a
42	CTCF	chr5:16741120-16741270	HBMEC	blood vessel:	n/a	n/a
43	CTCF	chr5:16741100-16741250	HCPEpiC	choroid plexus:	n/a	n/a
44	CTCF	chr5:16741140-16741295	Gliobla	brain:	n/a	n/a
45	CTCF	chr5:16741100-16741250	MCF-7	breast:	n/a	n/a
46	CTCF	chr5:16741130-16741311	HepG2	liver:	n/a	n/a
47	CTCF	chr5:16740260-16740410	BJ	skin:	n/a	n/a
48	CTCF	chr5:16741100-16741250	HCT-116	colon:	n/a	n/a
49	CTCF	chr5:16741100-16741250	HPF	lung:	n/a	n/a
50	CTCF	chr5:16741160-16741310	HepG2	liver:	n/a	n/a

(count:550 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:16742179-16742229	AG10803	skin:	n/a
2	chr5:16742179-16742229	AG10803	skin:	n/a
3	chr5:16742179-16742229	MCF10A-Er-Src	breast:	n/a
4	chr5:16742179-16742229	Hepatocyte	liver:	n/a
5	chr5:16742020-16742070	K562	blood:	n/a
6	chr5:16743265-16743315	LNCaP	prostate:	n/a
7	chr5:16742020-16742070	LNCaP	prostate:	n/a
8	chr5:16738125-16738175	HL-60	blood:	n/a
9	chr5:16738047-16738097	SK-N-SH_RA	brain:	n/a
10	chr5:16742054-16742104	GM06990	blood:	n/a
11	chr5:16737972-16738022	ECC-1	luminal epithelium:	n/a
12	chr5:16742179-16742229	HL-60	blood:	n/a
13	chr5:16742179-16742229	HUVEC	blood vessel:	n/a
14	chr5:16738047-16738097	SK-N-MC	brain:	n/a
15	chr5:16738125-16738175	GM19239	blood:	n/a
16	chr5:16742179-16742229	ECC-1	luminal epithelium:	n/a
17	chr5:16743265-16743315	GM12891	blood:	n/a
18	chr5:16738049-16738099	PFSK-1	brain:	n/a
19	chr5:16738318-16738368	NHDF-neo	bronchial:	n/a
20	chr5:16738318-16738368	GM06990	blood:	n/a
21	chr5:16738049-16738099	CMK	blood:	n/a
22	chr5:16738049-16738099	NB4	blood:	n/a
23	chr5:16742054-16742104	SKMC	muscle:	n/a
24	chr5:16737972-16738022	H1-hESC	embryonic stem cell:	embryo
25	chr5:16742054-16742104	HL-60	blood:	n/a
26	chr5:16738047-16738097	NHDF-neo	bronchial:	n/a
27	chr5:16742054-16742104	IMR90	lung:	fetal
28	chr5:16742179-16742229	U87	brain:	n/a
29	chr5:16743265-16743315	MCF-7	breast:	n/a
30	chr5:16742020-16742070	GM06990	blood:	n/a
31	chr5:16743265-16743315	IMR90	lung:	fetal
32	chr5:16738318-16738368	SK-N-MC	brain:	n/a
33	chr5:16738047-16738097	AG04450	lung:	fetal
34	chr5:16737972-16738022	NHDF-neo	bronchial:	n/a
35	chr5:16738318-16738368	NH-A	brain:	n/a
36	chr5:16737972-16738022	HL-60	blood:	n/a
37	chr5:16742179-16742229	GM19239	blood:	n/a
38	chr5:16742020-16742070	SK-N-MC	brain:	n/a
39	chr5:16738125-16738175	HIPEpiC	eye:	n/a
40	chr5:16738318-16738368	RPTEC	kidney:	n/a
41	chr5:16743265-16743315	CMK	blood:	n/a
42	chr5:16743265-16743315	AG09309	skin:	n/a
43	chr5:16742054-16742104	HCPEpiC	choroid plexus:	n/a
44	chr5:16742179-16742229	T-47D	breast:	n/a
45	chr5:16737972-16738022	AG09319	gingival:	n/a
46	chr5:16742179-16742229	NHDF-neo	bronchial:	n/a
47	chr5:16738318-16738368	ECC-1	luminal epithelium:	n/a
48	chr5:16742054-16742104	MCF10A-Er-Src	breast:	n/a
49	chr5:16742020-16742070	A549	lung:	n/a
50	chr5:16742179-16742229	ProgFib	skin:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:16744561..16747041-chr5:16752220..16754067,2	K562	blood:
2	chr5:16743803..16745620-chr5:16745640..16748516,2	K562	blood:
3	chr5:16740410..16741382-chr5:17189423..17190130,2	MCF-7	breast:
4	chr5:16740780..16741704-chr5:16776541..16777578,3	MCF-7	breast:
5	chr5:16626745..16627365-chr5:16744383..16745128,3	MCF-7	breast:
6	chr5:16744168..16745132-chr5:16787048..16788082,8	MCF-7	breast:
7	chr5:16735245..16737580-chr5:16952824..16955569,2	MCF-7	breast:
8	chr5:16734341..16736922-chr5:16738909..16741583,2	MCF-7	breast:
9	chr5:16588242..16589198-chr5:16744257..16744813,2	MCF-7	breast:
10	chr5:16626745..16627365-chr5:16744294..16745128,4	MCF-7	breast:
11	chr5:16740840..16741721-chr5:16776516..16777353,6	MCF-7	breast:
12	chr5:16588242..16589515-chr5:16744207..16745107,7	MCF-7	breast:
13	chr5:16743803..16745620-chr5:16745640..16748516,2	K562	blood:
14	chr5:16744168..16745132-chr5:16787048..16788082,5	MCF-7	breast:

No data

Variant related genes	Relation type
MYO10	TF binding region
MYO10	CpG island

Extended variants
information (count: 384 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:384 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11133857	chr5:16737513-16737514	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs369954735	chr5:16737526-16737527	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs375576591	chr5:16737536-16737537	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs547799695	chr5:16737540-16737541	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs137865401	chr5:16737547-16737548	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs539761433	chr5:16737626-16737627	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs551396333	chr5:16737651-16737652	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs73755168	chr5:16737667-16737668	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs142376483	chr5:16737683-16737684	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs76878732	chr5:16737687-16737688	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs567055460	chr5:16737689-16737690	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs144379510	chr5:16737719-16737720	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs148386319	chr5:16737720-16737721	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs577576492	chr5:16737731-16737732	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs546430632	chr5:16737782-16737783	Active TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs34390419	chr5:16737815-16737816	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs113381666	chr5:16737823-16737824	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs111283267	chr5:16737827-16737828	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs544066711	chr5:16737828-16737829	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs372597296	chr5:16737844-16737845	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs529453417	chr5:16737876-16737877	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs563299122	chr5:16737919-16737920	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs559657152	chr5:16737927-16737928	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs533172962	chr5:16737931-16737932	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs551625758	chr5:16737972-16737973	Active TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs192136636	chr5:16738005-16738006	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs73755170	chr5:16738031-16738032	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs73755172	chr5:16738032-16738033	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs73755174	chr5:16738049-16738050	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs547441167	chr5:16738077-16738078	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs139359363	chr5:16738111-16738112	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs565636556	chr5:16738125-16738126	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs143891423	chr5:16738126-16738127	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs112434053	chr5:16738188-16738189	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs538274139	chr5:16738191-16738192	Active TSS Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs558476142	chr5:16738218-16738219	Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs529701271	chr5:16738258-16738259	Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs7730335	chr5:16738319-16738320	Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs17583272	chr5:16738335-16738336	Active TSS Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs561052266	chr5:16738458-16738459	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs371314104	chr5:16738463-16738464	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs17429640	chr5:16738485-16738486	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs56058327	chr5:16738610-16738611	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs541466189	chr5:16738633-16738634	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs147276228	chr5:16738637-16738638	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs140683165	chr5:16738675-16738676	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs184223348	chr5:16738685-16738686	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs560508489	chr5:16738710-16738711	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs530760169	chr5:16738713-16738714	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs58909660	chr5:16738734-16738735	Active TSS Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:533 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:16730800-16741400	Strong transcription	A549	lung
2	chr5:16730800-16744400	Weak transcription	HSMM	muscle
3	chr5:16733600-16737800	Enhancers	Fetal Kidney	kidney
4	chr5:16734200-16737800	Weak transcription	Fetal Muscle Trunk	muscle
5	chr5:16734600-16744400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr5:16734800-16739200	Enhancers	Pancreas	Pancrea
7	chr5:16735000-16737800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
8	chr5:16735000-16738600	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr5:16735000-16738600	Enhancers	Fetal Lung	lung
10	chr5:16735000-16739400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr5:16735000-16739400	Enhancers	Stomach Mucosa	stomach
12	chr5:16735200-16738200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr5:16735200-16738400	Weak transcription	Muscle Satellite Cultured Cells	--
14	chr5:16735200-16746600	Weak transcription	HSMMtube	muscle
15	chr5:16735400-16737800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr5:16735400-16738000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr5:16735600-16737800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr5:16735600-16738400	Enhancers	NH-A	brain
19	chr5:16735800-16738400	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
20	chr5:16736000-16737600	Enhancers	NHLF	lung
21	chr5:16736000-16738200	Bivalent/Poised TSS	HepG2	liver
22	chr5:16736000-16738400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
23	chr5:16736000-16738400	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr5:16736000-16738800	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr5:16736200-16738000	Flanking Active TSS	Fetal Brain Female	brain
26	chr5:16736200-16738400	Transcr. at gene 5' and 3'	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr5:16736200-16738400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr5:16736200-16738400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr5:16736200-16738600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr5:16736400-16738800	Active TSS	ES-I3 Cell Line	embryonic stem cell
31	chr5:16736400-16739200	Enhancers	HMEC	breast
32	chr5:16736400-16740200	Weak transcription	Right Ventricle	heart
33	chr5:16736400-16781400	Weak transcription	Esophagus	oesophagus
34	chr5:16736600-16737600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr5:16736600-16737600	Enhancers	NHEK	skin
36	chr5:16736600-16738600	Active TSS	iPS-15b Cell Line	embryonic stem cell
37	chr5:16736600-16738600	Active TSS	Rectal Mucosa Donor 29	rectum
38	chr5:16736600-16738800	Active TSS	H1 Cell Line	embryonic stem cell
39	chr5:16736600-16740400	Weak transcription	Placenta Amnion	Placenta Amnion
40	chr5:16736800-16737600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
41	chr5:16736800-16737800	Weak transcription	Lung	lung
42	chr5:16736800-16738000	Active TSS	iPS-18 Cell Line	embryonic stem cell
43	chr5:16736800-16738200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr5:16736800-16738600	Active TSS	H9 Cell Line	embryonic stem cell
45	chr5:16736800-16738600	Active TSS	Brain Germinal Matrix	brain
46	chr5:16736800-16738600	Active TSS	Brain Inferior Temporal Lobe	brain
47	chr5:16736800-16738800	Active TSS	HUES48 Cell Line	embryonic stem cell
48	chr5:16736800-16739200	Enhancers	HUVEC	blood vessel
49	chr5:16736800-16740200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr5:16736800-16740600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links